A groundbreaking clinical trial is investigating stress induced opioid misuse mechanisms in chronic back pain patients by examining how acute stress modulates endogenous opioid and endocannabinoid systems. This research could identify biomarkers that predict which patients face heightened addiction risk during stressful periods. Understanding these neurobiological pathways may transform how clinicians assess and manage opioid prescribing for vulnerable populations.